Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$1K Hold
8
﹤0.01% 673
2020
Q1
$1K Hold
8
﹤0.01% 685
2019
Q4
$0 Hold
8
﹤0.01% 735
2019
Q3
$0 Hold
8
﹤0.01% 700
2019
Q2
$0 Hold
8
﹤0.01% 726
2019
Q1
$0 Hold
8
﹤0.01% 733
2018
Q4
$0 Hold
8
﹤0.01% 747
2018
Q3
$0 Hold
8
﹤0.01% 825
2018
Q2
$0 Hold
8
﹤0.01% 839
2018
Q1
$0 Sell
8
-4
-33% -$59 ﹤0.01% 829
2017
Q4
$0 Buy
+12
New +$156 ﹤0.01% 922

Other funds holding DXCM

TrueWealth LLC's DXCM Position: Q2 2020 in Review

TrueWealth LLC held its DexCom (DXCM) position steady in Q2 2020 at 8 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #673.

TrueWealth LLC first reported a position in DXCM in Q4 2017 and has held it in 11 quarters since. 723 funds tracked by Wall St. Rank hold DXCM as of Q2 2020.

  • TrueWealth LLC held 8 shares of DexCom worth $1K as of Q2 2020.
  • TrueWealth LLC left its DexCom share count unchanged in Q2 2020.
  • DexCom made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #673 holding.
  • TrueWealth LLC first reported a position in DexCom in Q4 2017 and has held it in 11 quarters since.
  • 723 funds tracked by Wall St. Rank held DexCom as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.